x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

North America ( XML Feed )

Aug 2, 2016 4:20 EST

GeneYouIn (GYI) is a Canadian personalized medicine company. Our vision for GYI is based upon an optimal balance of clinical utility, patient empowerment, and cost-efficient, targeted genome analysis.

iCrowdNewswire - Aug 2, 2016

Logo

GeneYouIn

 

GeneYouIn’s vision for GYI is based upon an optimal balance of clinical utility, patient empowerment, and cost-efficient, targeted genome analysis.

Company Summary

 

GeneYouIn (GYI) is a Canadian personalized medicine company. Our vision for GYI is based upon an optimal balance of clinical utility, patient empowerment, and cost-efficient, targeted genome analysis.

PillCheck  (https://pillcheck.geneyouin.ca), our proprietary genome analytics and reporting platform, provides personalized, actionable recommendations for the selection of ~1/3 of all drugs dispensed in North America, and is primarily used for chronic care management. PillCheck is marketed as a drug response test, and it addresses variability in medication response to improve the benefit/risk ratio for patients, and to reduce exposure to unnecessary costs for payers. It represents $2B market opportunity in Canada. 
PillCheck eliminates all barriers to genomic implementation and allows GYI’s channel partners – Health services companies, Benefits management companies, and Clinical Labs – to easily and rapidly add sophisticated genomic decision support to their product suites.
GYI already supplies PillCheck software to two CLIA-labs in United States, and established channel partnerships with Canadian firms: National Health Benefits Provider, Specialty Pharmacy Group and Integrated Health Clinics. FY2015 revenue: $410K. 
PillCheck platform allows for multiple integration points for health services but it puts consumer/patient in control.   Because PillCheck report contains evidence-based drug dosage recommendations and detailed references for 65+ meds, it brings necessary clarity to making important clinical decisions to all practitioners with whom patient chooses to interact – from his/her dentist to pharmacist to benefits case managers. 
Our roadmap includes extension of PillCheck to other forms of genomic data, beyond PGx, such as nutrition, and application of PGx insights to evidence-based tiered drug formulary design.

 
  • Stage$500K in TTM Revenue
  • IndustryHealthcare Services
  • LocationToronto, ON, Canada
  • CurrencyCAD
  • FoundedDecember 2012
  • Employees12
  • Websitepillcheck.geneyouin.ca

 

Team

  • 14e36ba6 8a02 4936 a47e de69a5f1e556
    VP IT Operations

    He brings industry leading practices in data encryption and security to the GeneYouIn technology.
    • Expert in system design, networking, security, system administration, vendor selection and management. Cloud services for Commtouch Software (NASDAQ:CYRN).
    • Personable, pragmatic and driven customer-facing technology leader. Has delivered complex IT projects to customers in finance and security sectors

     

  • trailblazer in personalized medicine, a molecular geneticist and technology builder. His vision for GeneYouIn is based upon an optimal balance of clinical utility, patient empowerment, and cost-efficient, targeted genome analysis.
    • Managed large-scale R&D programs at Sick Kids
    • Expertise in pain genetics.
    • Advised Bridgepoint and Mt. Sinai hospitals on implementation of personalized medicine programs.

     

  • Default avatar
    Antoine Levaivre
    SVP strategy & Partnerships
    Unconfirmed

    Expert alliance builder, deal-maker and a veteran in the pharmaceutical supply chain, healthcare IT, and private payer sectors in Canada. Antoine works with commercial and government payers to establish coverage and value-based reimbursement for PillCheck.
    • Oversaw development of the Health Analytics business at Telus
    • Led expansion of AmeriSource Bergen (NYCE:ABC) in Canada.
    • Grew hospital business at McKesson Canada from $20MM to $800MM.

     

  • Company builder, health technology innovator and financier. Her expertise in launching innovative products in the medical sector, building teams and developing winning commercial alliances, underpin the growth trajectory at GeneYouIn.
    • Led launch and development of Cogniciti (www.cogniciti.com).
    • Led the Health Care and Life Sciences practice at MaRS Discovery District.
    • Venture Finance Partnerships at GATX Capital i.

     

  • Default avatar
    Garry Siscos
    CFO
    Unconfirmed

    Brings with him over 30 years of experience in finance, accounting, growing sales organizations, and scaling up software companies.
    • Has held CFO positions throughout North America.
    • Sold a software company to Reed Exhibits.
    • Advised on M&A, ranging in value from $500,000 to $20 million. Managed tax practice for PWC Canada.

Contact Information:

Ruslan Dorfman

View Related News >
support